文献速递小儿耳鼻咽喉睡眠呼吸障碍

儿童阻塞性睡眠呼吸暂停腺样体扁桃体切除术后血清生物标志物:系统综述与Meta分析

Serum Biomarkers after Adenotonsillectomy for Pediatric OSA: A Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2024-02-21

该系统综述与Meta分析检索PubMed、Embase和Cochrane数据库至2022年8月16日,纳入26项研究共1331例多导睡眠图诊断的儿童阻塞性睡眠呼吸暂停患者,评估腺样体扁桃体切除术后血清标志物变化;Meta分析显示术后胰岛素、C反应蛋白和脑钠肽水平显著降低,胰岛素样生长因子1水平显著升高,甘油三酯、总胆固醇、肿瘤坏死因子α、低密度脂蛋白、高密度脂蛋白、血糖、白细胞介素10和白细胞介素6无显著变化。

要点

  • 腺样体扁桃体切除术后胰岛素水平显著降低(SMD=-0.322,95%CI -0.583至-0.061)。
  • 术后C反应蛋白显著降低(SMD=-0.946,95%CI -1.578至-0.314),脑钠肽显著降低(SMD=-1.416,95%CI -2.355至-0.477)。
  • 术后胰岛素样生长因子1显著升高(SMD=0.691,95%CI 0.207至1.176)。

核心结论

  • 在多导睡眠图诊断的儿童阻塞性睡眠呼吸暂停中,腺样体扁桃体切除术与血清生物标志物改善相关,包括C反应蛋白、胰岛素和脑钠肽降低,胰岛素样生长因子1升高。

研究设计与样本

  • 系统综述与Meta分析,由两位作者独立检索PubMed、Embase和Cochrane数据库截至2022年8月16日的文献;筛选1616项研究,纳入26项研究共1331例参与者,对其中20项研究进行Meta分析。

主要发现

  • 腺样体扁桃体切除术后胰岛素水平显著降低(SMD=-0.322,95%CI -0.583至-0.061)。
  • 术后C反应蛋白显著降低(SMD=-0.946,95%CI -1.578至-0.314)。
  • 术后脑钠肽显著降低(SMD=-1.416,95%CI -2.355至-0.477)。
  • 术后胰岛素样生长因子1显著升高(SMD=0.691,95%CI 0.207至1.176)。
  • 甘油三酯、总胆固醇、肿瘤坏死因子α、低密度脂蛋白、高密度脂蛋白、血糖、白细胞介素10和白细胞介素6水平无显著变化。

关键数值与推荐

  • 采用随机效应模型计算标准化均数差(SMD),并对腺样体扁桃体切除术后显示统计学显著效应的结局计算获益概率(POB)和需治疗人数(NNT)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether adenotonsillectomy improves levels of inflammatory and cardiometabolic markers in children with polysomnographically diagnosed obstructive sleep apnea (OSA). DATA SOURCES: Two authors independently searched PubMed, Embase, and Cochrane databases up to August 16, 2022, for studies relating to pre- and post-operative levels of serum markers in pediatric patients undergoing adenotonsillectomy. REVIEW METHODS: Data were extracted from included articles into a structured proforma. Meta-analyses of the standardized mean difference (SMD) were conducted in random-effects models. We calculated the probability of benefit (POB) and number needed to treat (NNT) for outcomes that demonstrated a statistically significant effect after adenotonsillectomy. The primary outcomes were changes in serum markers including C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), Insulin-like growth factor 1 (IGF-1), interleukin-10 (IL-10), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), Brain natriuretic peptide (BNP), insulin, glucose, total cholesterol, triglyceride, low-density lipoprotein (LDL), high-density lipoprotein (HDL). RESULTS: We screened 1616 studies and included 26 studies with 1331 participants. Meta-analysis was performed on 20 of the included studies. Adenotonsillectomy was associated with a significant decrease in insulin levels (SMD = -0.322, 95% Confidence Interval (CI) = -0.583 to -0.061), CRP (SMD = -0.946, 95% CI = -1.578 to -0.314), and BNP (SMD = -1.416, 95% CI = -2.355 to -0.477) and significant increase in levels of IGF-1 (SMD = 0.691, 95% CI = 0.207 to 1.176). There were no significant changes in levels of triglyceride, total cholesterol, TNF-α, LDL, HDL, glucose, IL-10, and IL-6. CONCLUSION: In children with polysomnographically diagnosed OSA, adenotonsillectomy was associated with improvements in serum biomarkers, comprising lower CRP, insulin, and BNP, and higher IGF-1. Laryngoscope, 134:3030-3037, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Ding Y, Koh JH, Cheah XY, et al. Serum Biomarkers after Adenotonsillectomy for Pediatric OSA: A Systematic Review and Meta-Analysis. Laryngoscope. 2024. PMID: 38380991. doi:10.1002/lary.31249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。